vs
Consensus Cloud Solutions, Inc.（CCSI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Consensus Cloud Solutions, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$87.1M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.1%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $7.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.6%）
Consensus Cloud Solutions是一家云解决方案提供商，核心产品包括加密数字传真、安全文档交换、工作流程自动化工具，主要面向医疗、法律、金融服务等领域的北美企业客户提供相关服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CCSI vs PBYI — 直观对比
营收规模更大
CCSI
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出27.6%
0.1%
自由现金流更多
PBYI
多$7.1M
$7.3M
两年增速更快
PBYI
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $87.1M | $75.5M |
| 净利润 | $20.5M | — |
| 毛利率 | 80.0% | 69.3% |
| 营业利润率 | 41.1% | 22.7% |
| 净利率 | 23.5% | — |
| 营收同比 | 0.1% | 27.7% |
| 净利润同比 | 13.5% | — |
| 每股收益（稀释后） | $1.06 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCSIPBYI
| Q4 25 | $87.1M | $75.5M | ||
| Q3 25 | $87.8M | $54.5M | ||
| Q2 25 | $87.7M | $52.4M | ||
| Q1 25 | $87.1M | $46.0M | ||
| Q4 24 | $87.0M | $59.1M | ||
| Q3 24 | $87.8M | $80.5M | ||
| Q2 24 | $87.5M | $47.1M | ||
| Q1 24 | $88.1M | $43.8M |
净利润CCSIPBYI
| Q4 25 | $20.5M | — | ||
| Q3 25 | $22.1M | $8.8M | ||
| Q2 25 | $20.8M | $5.9M | ||
| Q1 25 | $21.2M | $3.0M | ||
| Q4 24 | $18.1M | — | ||
| Q3 24 | $21.1M | $20.3M | ||
| Q2 24 | $23.9M | $-4.5M | ||
| Q1 24 | $26.4M | $-4.8M |
毛利率CCSIPBYI
| Q4 25 | 80.0% | 69.3% | ||
| Q3 25 | 80.0% | 77.7% | ||
| Q2 25 | 79.9% | 76.5% | ||
| Q1 25 | 79.3% | 77.1% | ||
| Q4 24 | 79.5% | 76.4% | ||
| Q3 24 | 79.9% | 63.9% | ||
| Q2 24 | 80.4% | 77.4% | ||
| Q1 24 | 80.7% | 75.5% |
营业利润率CCSIPBYI
| Q4 25 | 41.1% | 22.7% | ||
| Q3 25 | 43.2% | 17.6% | ||
| Q2 25 | 44.5% | 12.7% | ||
| Q1 25 | 43.0% | 8.7% | ||
| Q4 24 | 38.4% | 22.6% | ||
| Q3 24 | 43.8% | 27.4% | ||
| Q2 24 | 45.6% | -4.6% | ||
| Q1 24 | 42.7% | -5.3% |
净利率CCSIPBYI
| Q4 25 | 23.5% | — | ||
| Q3 25 | 25.2% | 16.2% | ||
| Q2 25 | 23.7% | 11.2% | ||
| Q1 25 | 24.3% | 6.5% | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 24.1% | 25.2% | ||
| Q2 24 | 27.3% | -9.6% | ||
| Q1 24 | 29.9% | -11.0% |
每股收益（稀释后）CCSIPBYI
| Q4 25 | $1.06 | $0.26 | ||
| Q3 25 | $1.15 | $0.17 | ||
| Q2 25 | $1.07 | $0.12 | ||
| Q1 25 | $1.07 | $0.06 | ||
| Q4 24 | $0.92 | $0.40 | ||
| Q3 24 | $1.09 | $0.41 | ||
| Q2 24 | $1.24 | $-0.09 | ||
| Q1 24 | $1.37 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.7M | $97.5M |
| 总债务越低越好 | $558.4M | $22.7M |
| 股东权益账面价值 | $13.8M | $130.3M |
| 总资产 | $663.8M | $216.3M |
| 负债/权益比越低杠杆越低 | 40.54× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CCSIPBYI
| Q4 25 | $74.7M | $97.5M | ||
| Q3 25 | $97.6M | $94.4M | ||
| Q2 25 | $57.9M | $96.0M | ||
| Q1 25 | $53.4M | $93.2M | ||
| Q4 24 | $33.5M | $101.0M | ||
| Q3 24 | $54.6M | $96.7M | ||
| Q2 24 | $49.2M | $96.8M | ||
| Q1 24 | $61.5M | $107.2M |
总债务CCSIPBYI
| Q4 25 | $558.4M | $22.7M | ||
| Q3 25 | $578.6M | $34.0M | ||
| Q2 25 | $578.2M | $45.3M | ||
| Q1 25 | $583.7M | $56.7M | ||
| Q4 24 | $593.0M | $68.0M | ||
| Q3 24 | $612.5M | $79.3M | ||
| Q2 24 | $642.8M | $90.7M | ||
| Q1 24 | $671.7M | $102.0M |
股东权益CCSIPBYI
| Q4 25 | $13.8M | $130.3M | ||
| Q3 25 | $-2.6M | $115.3M | ||
| Q2 25 | $-26.5M | $104.7M | ||
| Q1 25 | $-49.4M | $97.1M | ||
| Q4 24 | $-79.5M | $92.1M | ||
| Q3 24 | $-93.2M | $71.1M | ||
| Q2 24 | $-124.4M | $48.5M | ||
| Q1 24 | $-151.8M | $51.0M |
总资产CCSIPBYI
| Q4 25 | $663.8M | $216.3M | ||
| Q3 25 | $675.0M | $202.9M | ||
| Q2 25 | $641.5M | $194.9M | ||
| Q1 25 | $629.6M | $196.2M | ||
| Q4 24 | $602.2M | $213.3M | ||
| Q3 24 | $622.5M | $220.7M | ||
| Q2 24 | $608.5M | $205.0M | ||
| Q1 24 | $620.8M | $214.1M |
负债/权益比CCSIPBYI
| Q4 25 | 40.54× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $7.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 8.4% | 19.1% |
| 资本支出强度资本支出/营收 | 9.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.74× | — |
| 过去12个月自由现金流最近4个季度 | $105.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CCSIPBYI
| Q4 25 | $15.2M | $14.4M | ||
| Q3 25 | $51.6M | $9.7M | ||
| Q2 25 | $28.3M | $14.1M | ||
| Q1 25 | $40.9M | $3.6M | ||
| Q4 24 | $11.1M | $15.6M | ||
| Q3 24 | $41.6M | $11.0M | ||
| Q2 24 | $24.4M | $1.0M | ||
| Q1 24 | $44.7M | $11.2M |
自由现金流CCSIPBYI
| Q4 25 | $7.3M | $14.4M | ||
| Q3 25 | $44.4M | $9.7M | ||
| Q2 25 | $20.3M | $14.1M | ||
| Q1 25 | $33.7M | $3.6M | ||
| Q4 24 | $3.1M | $15.6M | ||
| Q3 24 | $33.6M | $11.0M | ||
| Q2 24 | $15.8M | $1.0M | ||
| Q1 24 | $35.8M | — |
自由现金流率CCSIPBYI
| Q4 25 | 8.4% | 19.1% | ||
| Q3 25 | 50.6% | 17.7% | ||
| Q2 25 | 23.2% | 26.8% | ||
| Q1 25 | 38.7% | 7.7% | ||
| Q4 24 | 3.6% | 26.4% | ||
| Q3 24 | 38.3% | 13.7% | ||
| Q2 24 | 18.1% | 2.1% | ||
| Q1 24 | 40.6% | — |
资本支出强度CCSIPBYI
| Q4 25 | 9.1% | 0.0% | ||
| Q3 25 | 8.2% | 0.0% | ||
| Q2 25 | 9.1% | 0.0% | ||
| Q1 25 | 8.3% | 0.1% | ||
| Q4 24 | 9.2% | 0.0% | ||
| Q3 24 | 9.1% | 0.0% | ||
| Q2 24 | 9.8% | 0.0% | ||
| Q1 24 | 10.1% | 0.0% |
现金转化率CCSIPBYI
| Q4 25 | 0.74× | — | ||
| Q3 25 | 2.34× | 1.10× | ||
| Q2 25 | 1.36× | 2.41× | ||
| Q1 25 | 1.94× | 1.21× | ||
| Q4 24 | 0.62× | — | ||
| Q3 24 | 1.97× | 0.54× | ||
| Q2 24 | 1.02× | — | ||
| Q1 24 | 1.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
